Life SciencesLiability

TL;DR

Lab insurance for CLIA-certified clinical, pathology, molecular, and bioanalytical labs is structured around three coverages: cyber liability sized to annual specimen volume and PHI sensitivity (not lab headcount), professional liability for diagnostic accuracy (the highest claim severity category), and hospital reference-lab service agreement compliance. Ransomware operational interruption is the single biggest claim category and most generalist laboratory insurance programs under-cover it.

Lab Insurance · Diagnostic & Clinical Labs · Texas

Lab insurance for CLIA-certified diagnostic, pathology, and bioanalytical labs. Ransomware on labs surged 264% - your CAP renewal is in 90 days.

Laboratory insurance for Texas CLIA-certified labs covers HIPAA-scale PHI exposure, hospital reference-lab service agreements, payor network credentialing, and accreditation cycles (CAP, COLA) under one coordinated specialty placement.

We help mid-market clinical labs, anatomic pathology, molecular diagnostics, and bioanalytical contract labs build lab insurance programs that respond to professional liability for diagnostic accuracy, ransomware on PHI, and hospital procurement requirements.

Problem 01 · Cyber exposure

Ransomware on PHI-rich labs is a structural threat.

Labs hold massive volumes of PHI under HIPAA and Texas HB300. Ransomware attacks targeting clinical labs surged 264% in 2024-2025. A standalone cyber policy with regulatory defense, notification expense, and ransomware coverage is essential - not optional.

Coordination matters: a ransomware event affecting LIS systems can result in delayed test results, missed clinical decisions, and downstream professional-liability claims. Cyber and PL written by carriers that play together avoid coverage fights at claim time.

Problem 02 · Professional liability

Diagnostic accuracy claims have real severity.

Diagnostic accuracy claims (missed cancer diagnoses, false positives, sample mix-ups) drive professional liability exposure that scales with test volume and complexity. Molecular diagnostics and oncology dx have higher claim severity than routine clinical chemistry.

CAP and COLA accreditation reduce underwriting friction (carriers see them as quality signals) and are sometimes credit factors on professional-liability premiums. Hospital reference-lab contracts typically require accreditation as a baseline.

Problem 03 · Hospital reference-lab contracts

Service agreements have specific insurance schedules.

Service agreements with hospital systems carry insurance schedules typically requiring $1M/$3M professional liability, $5M+ cyber, additional-insured for the hospital, and 30-day notice. The COI is reviewed at credentialing and at renewal - gaps trigger contract suspension.

Bioanalytical contract labs serving pharma R&D operate under different documents - sponsor agreements, GLP compliance, and CTA-style insurance schedules. The decoder framework that applies to sponsor MSAs maps onto these too; clinical-lab payor contract decoder applies less.

Problem 01 · Cyber sized to specimen volume

Cyber liability is driven by annual specimen volume and PHI sensitivity, not lab headcount.

A 100-employee clinical lab processing 1M specimens annually faces breach exposure proportional to the 1M-patient-event dataset, not the 100 employees. Most generalist cyber programs are sized to revenue and headcount, which materially under-sizes the actual HIPAA exposure.

High-volume hospital reference labs commonly need $25M-$50M cyber. Molecular diagnostic labs handling genomic data trigger additional state genetic privacy statute exposure. The placement requires a carrier with healthcare cyber appetite sized to specimen volume.

Problem 02 · Ransomware operational interruption

Ransomware operational interruption is the single biggest claim category.

Ransomware on a clinical lab's LIS, middleware, or specimen tracking system halts specimen processing and result reporting until restored. Daily revenue loss can be substantial; downstream hospital operational impact creates additional contingent business interruption exposure.

Most generalist cyber programs under-cover ransomware operational interruption. Specialty placements include explicit specimen-processing-downtime BI coverage with appropriate waiting periods.

Problem 03 · Diagnostic accuracy professional liability

Professional liability for diagnostic accuracy is the highest claim severity category.

Result-reporting accuracy claims (false negative, false positive, transcription error, sample switching) are the highest severity category for clinical labs. Anatomic pathology in particular generates claim severity comparable to medical professional liability.

Programs should include explicit diagnostic accuracy E&O at $5M-$10M with appropriate sublimits for specific exposure categories. Cyber and professional liability should be coordinated rather than left to default policy language.

Problem 04 · CAP / CLIA inspection defense

Accreditation inspection cycles create regulatory defense exposure.

CAP and CLIA inspection cycles create routine regulatory defense exposure. Deficiency citations, condition-level findings, and corrective action plans require legal and regulatory support that some standard programs do not include.

Specialty programs include explicit CAP/CLIA inspection defense scope, plus HHS OCR breach response coordination for HIPAA-triggered events. The dollar amounts per proceeding are typically modest but the cumulative drain and license-at-risk severity make dedicated coverage load-bearing.

Carrier access

We place clinical lab programs through specialty healthcare and life-sciences underwriters.

Generalist healthcare carriers will write a clinical lab as a medical office. The placement looks fine on the COI. The placement fails at first cyber event, when it turns out the cyber under-sized PHI volume or the ransomware operational interruption is excluded.

Our placements run through carriers with dedicated clinical lab and diagnostic underwriting and, for high-volume hospital reference labs, surplus-lines specialty markets. We know which carriers write LDT specialty labs at competitive terms vs which restrict appetite.

Programs anchored in Texas with broader placement across the major US life-sciences clusters - including the New Jersey pharma corridor and the North Carolina (RTP) cluster.

Pricing

Wondering what this typically costs?

Premium ranges for CLIA-certified clinical labs at $5M-$50M revenue, the factors that drive cost, and sample programs by specimen volume and lab category.

Frequently asked

Common questions from clinical and diagnostic lab operators

What insurance does a CLIA-certified lab need?

Professional liability for diagnostic accuracy (missed cancer dx is a live tort), general liability, products if you do kits or LDTs, cyber for HIPAA-scale PHI exposure, crime, property for instruments, and auto for specimen-pickup fleets.

Why is cyber so important for clinical labs?

Labs hold massive volumes of PHI under HIPAA and Texas HB300, and ransomware attacks on labs surged 264% in 2024-2025. A standalone cyber policy with notification expense, regulatory defense, and ransomware coverage is critical.

How does CAP or COLA accreditation affect insurance?

Accreditation reduces underwriting friction (carriers see it as a quality signal) and is sometimes a credit factor on professional-liability premiums. It is also typically required by hospital reference-lab contracts.

Do bioanalytical contract labs need different coverage than clinical labs?

Yes - bioanalytical labs serving pharma R&D operate under GLP and sponsor agreements rather than CLIA + payor contracts. The decoder framework for sponsor MSAs applies; clinical-lab payor contract decoder applies less.

What about LDTs (laboratory-developed tests)?

LDT insurance is in flux. The FDA LDT rule was vacated in March 2025 and is back in regulatory uncertainty. Labs running LDTs should carry products liability with explicit LDT language and stay close to regulatory developments.

How do hospital reference-lab service agreements affect coverage?

Hospital reference-lab service agreements typically require $1M/$3M professional liability, $5M+ cyber, additional-insured wording for the hospital, and 30-day notice. The COI is reviewed at credentialing and at renewal.

Authoritative references

Primary regulatory sources for diagnostic and clinical lab insurance

Why operators choose this practice

  • Life sciences only

    Every placement passes through specialty life-sciences underwriters - not a general manufacturer or healthcare desk.

  • All 50 US states

    Programs placed nationally with deep practice content for the 16 states anchoring the major US life-sciences clusters.

  • End-of-day SLA

    Coverage review requests come back the same business day. MSA reads are typically half an hour or less.

  • Decoder + glossary

    Free MSA Decoder, 49-clause glossary, 60+ Q&A library. Designed for CFOs, GCs, and Quality leaders.

Free coverage review

A specialist will reach out by end of business day.

No marketing sequences, no list rental. Half-hour MSA reads are the standard.

Get my coverage review

A specialist will reach out by end of business day.

Your details only schedule the review. No marketing sequences, no list rental.